End-point binding free energy calculation with MM/PBSA and MM/GBSA: strategies and applications in drug design

E Wang, H Sun, J Wang, Z Wang, H Liu… - Chemical …, 2019 - ACS Publications
Molecular mechanics Poisson–Boltzmann surface area (MM/PBSA) and molecular
mechanics generalized Born surface area (MM/GBSA) are arguably very popular methods …

Integrated approach to structure-based enzymatic drug design: molecular modeling, spectroscopy, and experimental bioactivity

B Honarparvar, T Govender, GEM Maguire… - Chemical …, 2014 - ACS Publications
Analysis of the literature involving computational modeling of diseases and drug design with
the aid of experimental spectroscopic techniques reveals that this specific combination of …

An integrated molecular dynamics, principal component analysis and residue interaction network approach reveals the impact of M184V mutation on HIV reverse …

S Bhakat, AJM Martin, MES Soliman - Molecular BioSystems, 2014 - pubs.rsc.org
The emergence of different drug resistant strains of HIV-1 reverse transcriptase (HIV RT)
remains of prime interest in relation to viral pathogenesis as well as drug development …

Understanding drug resistance of wild-type and L38HL insertion mutant of HIV-1 C protease to saquinavir

S Venkatachalam, N Murlidharan, SR Krishnan… - Genes, 2023 - mdpi.com
Acquired immunodeficiency syndrome (AIDS) is one of the most challenging infectious
diseases to treat on a global scale. Understanding the mechanisms underlying the …

Computing protein–protein association affinity with hybrid steered molecular dynamics

RA Rodriguez, L Yu, LY Chen - Journal of chemical theory and …, 2015 - ACS Publications
Computing protein–protein association affinities is one of the fundamental challenges in
computational biophysics/biochemistry. The overwhelming amount of statistics in the phase …

Purification and characterization of naturally occurring HIV-1 (South African subtype C) protease mutants from inclusion bodies

SB Maseko, S Natarajan, V Sharma… - Protein expression and …, 2016 - Elsevier
Human immunodeficiency virus (HIV) infections in sub-Saharan Africa represent about 56%
of global infections. Many studies have targeted HIV-1 protease for the development of …

Binding free energy calculations of nine FDA‐approved protease inhibitors against HIV‐1 subtype C I36T↑ T containing 100 amino acids per monomer

HA Lockhat, JRA Silva, CN Alves… - Chemical biology & …, 2016 - Wiley Online Library
In this work, have investigated the binding affinities of nine FDA‐approved protease inhibitor
drugs against a new HIV‐1 subtype C mutated protease, I36T↑ T. Without an X‐ray crystal …

Multi-drug resistance profile of PR20 HIV-1 protease is attributed to distorted conformational and drug binding landscape: molecular dynamics insights

S Chetty, S Bhakat, AJM Martin… - Journal of Biomolecular …, 2016 - Taylor & Francis
The PR20 HIV-1 protease, a variant with 20 mutations, exhibits high levels of multi-drug
resistance; however, to date, there has been no report detailing the impact of these 20 …

An in-silico layer-by-layer adsorption study of the interaction between Rebaudioside A and the T1R2 human sweet taste receptor: modelling and biosensing …

OA Arodola, S Kanchi, P Hloma, K Bisetty, AM Asiri… - Scientific Reports, 2020 - nature.com
The human sweet taste receptor (T1R2) monomer—a member of the G-protein coupled
receptor family that detects a wide variety of chemically and structurally diverse sweet tasting …

Possible allosteric binding site on Gyrase B, a key target for novel anti-TB drugs: homology modelling and binding site identification using molecular dynamics …

S Chetty, MES Soliman - Medicinal Chemistry Research, 2015 - Springer
Although tuberculosis (TB) is a treatable disease, it still impacts highly on the morbidity and
mortality of people in sub-Saharan Africa. This is largely attributed to drug resistance to the …